Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-25 @ 12:03 PM
NCT ID:
NCT04074161
Pre Assignment Details:
Total 338 adults with obesity (BMI greater than or equal to (\>=30.0) kilograms per square meter (kg/m\^2)) or overweight (BMI \>= 27.0 kg/m\^2) and at least one weight-related comorbidity were randomized in a 3:1:3:1 manner to receive treatment with either semaglutide subcutaneously (s.c.) 2.4 milligram (mg) once weekly or semaglutide placebo once weekly or liraglutide s.c. 3.0 mg once daily or liraglutide placebo once daily as an adjunct to a reduced-calorie diet and increased physical activity.
Recruitment Details:
The trial was conducted at 19 sites in the United States (US).
Study:
NCT04074161
Study Brief:
Results Section:
NCT04074161